The result demonstrated that NAP1L1 might accelerate the progression of HCC, which relies on the cell cycle (Figures 5A–D), especially the G2/M phase transition (Figures 5E–H) and Wnt signaling pathway (Figure 5I–L). Here, NAP1L1 is linked to hepatocellular carcinoma.